ShannonL.MeeksMD
Pediatric Hematology & Oncology • Atlanta, GAPediatric Coagulation Disorder Hematology
Professor of Pediatrics at Emory University School of Medicine; Program Director for Hemostasis and Thrombosis at Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta
Dr. Meeks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1405 Clifton Rd NE
Atlanta, GA 30322Phone+1 404-785-1112Fax+1 404-785-6288
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2004 - 2007
University of Virginia Medical CenterResidency, Pediatrics, 2001 - 2004
University of Mississippi School of MedicineClass of 2001
Certifications & Licensure
GA State Medical License 2004 - 2025
VA State Medical License 2001 - 2004- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Hemophilia Inhibitor Previously Untreated Patient Study Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 66 citationsEnhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction.Philip M. Zakas, Harrison C. Brown, Kristopher A. Knight, Shannon L. Meeks, H. Trent Spencer
Nature Biotechnology. 2017-01-01 - 57 citationsA microengineered vascularized bleeding model that integrates the principal components of hemostasis.Yumiko Sakurai, Elaissa T. Hardy, Byungwook Ahn, Reginald Tran, Meredith E. Fay
Nature Communications. 2018-02-06 - 98 citationsToward optimal therapy for inhibitors in hemophilia.Christine L. Kempton, Shannon L. Meeks
Blood. 2014-11-27
Abstracts/Posters
- Severe Bleeding Events in Hemophilia _ Patients Receiving Emicizumab ProphylaxisShannon L. Meeks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The Immune Response to Murine Factor VIII in Single Exon Deletion and Total Gene Deletion Murine Models of Hemophilia aShannon L. Meeks, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Hemlibra Given with Immune Tolerance Induction Safely Treats Children with Severe Hemophilia A, Study FindsSeptember 9th, 2019
Pediatric Hematologists Introduce a Novel Way to Treat Pediatric Hemophilia A PatientsAugust 29th, 2019
Grant Support
- Mechanisms Of Immunogenicity Of Factor VIIINational Heart, Lung, And Blood Institute2010–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
